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Dr Amy Reed (Cincinnati, OH). Were you able to look at the
asymptomatic vs symptomatic indication for carotid endarterec-
tomy and particularly look at how those high-risk patients did?
There have been studies that have shown that that is a particular
area where patients don’t do well and whether or not best medical
management might be better.
Dr Jeanwan Kang. The information that is available in the
NSQIP database is a history of previous neurologic event. What we
don’t know is the laterality or the timing of that event, so we are
not able to determine who underwent the surgery for symptomatic
vs asymptomatic disease.
What we are able to determine from the database is a group of
patient population who, for sure, is asymptomatic, mainly those
with absolutely no previous neurologic event, and in those patients
there was a slightly lower rate of stroke death rate, however it was
not statistically significant.
Dr Hasan Dosluoglu (Buffalo, NY). I enjoyed the talk and a
wealth of information from the private NSQIP data is going to
start coming out. I am surprised that 80% of the patients hadprocedure, I am surprised at that. Did the high-risk patients have
different outcomes in those who had a general anesthesia vs local
anesthesia? And second, maybe the high-risk patients were not too
high risk, because they could undergo general anesthesia in those
who had general anesthesia.
Dr Kang. To answer your first question, because the percent-
age of patients undergoing local anesthesia was less than 20%, that
came out to about a little over 600 patients undergoing carotid
endarterectomy under local anesthesia, so any sort of subanalysis
became meaningless because the numbers were so low.
The criteria for high risk were the same as that defined by the
SAPPHIRE study and there were about 30% of patients who met
these criteria. In addition, ASA [American Society of Anesthesiol-
ogists] class for each patient is available in the NSQIP database. I
have not shown these data here, but patients who were ASA class 3
or 4 made up majority of the patient population.
Dr Anton Sidawy (Washington, DC). We analyzed the VA
NSQIP data. There were over 20,000 carotid endarterectomies.
Although there was no significant difference in neurologic out-
comes based on different levels of renal insufficiency, 30-day
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were significantly increased. Have you adjusted your data for renal
failure?
DrKang. It certainly was. For stroke, renal failure was not one
of the variables that came out to be significant on univariate
analysis. And we looked at renal failure in many different ways. We
looked at it as a categorical variable as well as continuous variable.
We also calculated GFR and none of that made a difference interms of univariate analysis for stroke.It was, however, one of the
variables that came out to be significant for death. However, on
multivariate analysis, it was not one of the independent predictors
of death.
Having said that, the number of deaths that were studied in
our study were only 26; and so therefore, we could only say that
two of the highest, most significant variables on this multivariate
analysis were significant predictors of death.
